株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ポイントオブケア検査 (POCT) の世界市場:製品別 (血糖値計、血液ガス・電解質 (BGE) 解析装置、妊娠検査、感染症検査など) の将来展望

Global Point-of-Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022

発行 RNCOS E-Services Pvt. Ltd. 商品コード 409578
出版日 ページ情報 英文 90 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.91円で換算しております。
Back to Top
ポイントオブケア検査 (POCT) の世界市場:製品別 (血糖値計、血液ガス・電解質 (BGE) 解析装置、妊娠検査、感染症検査など) の将来展望 Global Point-of-Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022
出版日: 2018年09月14日 ページ情報: 英文 90 Pages
概要

当レポートでは、世界のポイントオブケア検査 (POCT) の関連市場について分析し、ポイントオブケア診断/検査の概要や、市場全体および製品別・地域の動向見通し、主な市場促進・抑制要因、主要企業のプロファイル・競争戦略、今後の技術開発・市場成長の方向性などについて調査しております。

第1章 アナリストの見解

第2章 分析手法

第3章 体外診断市場の概要

  • イントロダクション
  • 体外診断とは何か?
  • 市場規模・成長率

第4章 ポイントオブケア診断 (POCD):概要

第5章 市場のダイナミクス

  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第6章 ポイントオブケア検査 (POCT) 市場の将来展望

第7章 POCT市場:製品別

  • イントロダクション
    • 血糖モニタリングキット
    • 血液ガス・電解質解析装置
    • 妊娠・受精検査キット
    • 心臓マーカー
    • 感染症検査キット
    • 薬物乱用検査キット
    • その他

第8章 POCT市場:地域別

  • イントロダクション
    • 北米
    • 欧州
    • アジア太平洋地域
    • 他の国々 (RoW)

第9章 業界の傾向・動静

  • 携帯式超音波装置によるオンサイト (現地) での医療提供
  • マイクロフルイディクス (微小液体) 技術のPOCT産業への浸透

第10章 企業プロファイル

目次

Point-of-Care testing can be defined as the medical diagnostic testing performed outside the clinical laboratory near to the place where the patient is receiving treatment. This type of testing is performed by non-laboratory personnel and the results are used for clinical decision making. The Point-of-Care tests have immense potential to improve global health, and to eventually reduce public and national spending on health.

The Point-of-Care testing devices have now found applications in a large number of medical conditions. Due to its increased usage in the field of critical care settings to deliver decentralized, patient-centric healthcare to the patients, the projections for the global Point-of-Care testing market is expected to witness a rapid growth. It is predicted that by 2022, the global Point-of-Care testing market will reach U$$ 30 Billion.

As per RNCOS report "Global Point-of-Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022", the global Point-of-Care testing market is anticipated to witness a rapid growth during 2017-2022. This report provides a detailed analysis of the current and future market scenario of the global Point-of-Care testing market with a brief outlook of the IVD industry. The report provides insight about the major drivers, such as increasing awareness about POCT, technological advancements, increasing FDA approvals, for the global Point-of-Care testing market.

Furthermore, few challenges, such as product recalls and lack of regulatory standards, hindering the growth of the global Point-of-Care testing market have also been mentioned in the report. In addition, the report also highlights various opportunities available for growth of the global Point-of-Care testing market. Various trends and developments in the industry have also been cited in the report.

The global Point-of-Care testing market has been segmented on the basis of type of product. The major types of Point-of-Care testing present in the market include glucose monitoring kits, blood gas and electrolyte analysers, pregnancy & fertility testing kits, cardiac markers, infectious diseases testing kits, coagulation monitoring kits and drug-of-abuse testing kits amongst others. According to the report, glucose monitoring kits accounted for the largest share in 2017 due to rising prevalence of diabetes & technological advancements in self-monitoring of blood glucose. Based on geography, the report divides the market into North America, Europe, Asia-Pacific, and Rest of the World. In 2017, North America accounted for the largest share.

The last section of the report discusses about the prominent players in global Point-of-Care testing market. A brief business overview and financial information about each of these players has been provided, along with their product portfolios. The recent developments of every player have also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global Point-of-Care testing market.

Table of Contents

1. Analyst View

2. Research Methodology

3. In Vitro Diagnostic Market Overview

  • 3.1 Introduction
  • 3.2 What is In Vitro Diagnostics?
  • 3.3 Market Size and Growth

4. Point-of-Care Diagnostics: An Overview

5. Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 High Prevalence of Infectious and Lifestyle Related Diseases
    • 5.1.2 Rising Use of Home Based Point-of-Care Diagnostics
    • 5.1.3 Government Initiatives
    • 5.1.4 Technological Advancements
    • 5.1.5 Rising FDA Approvals
    • 5.1.6 Lack of Skilled Lab Personnel
    • 5.1.7 Rising Awareness about POCT
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
    • 5.2.2 Lack of Regulatory Standards
    • 5.2.3 Data Management & Connectivity
  • 5.3 Market Opportunities
    • 5.3.1 Physical Robotic Telepresence
    • 5.3.2 Smart Virtual Assistant in Association with Mobile Devices

6. Point-of-Care Testing Market Outlook 2022

7. Point-of-Care Testing Market, By Product

  • 7.1 Introduction
    • 7.1.1 Glucose Monitoring Kits
    • 7.1.2 Blood Gas and Electrolyte Analyzers
    • 7.1.3 Pregnancy & Fertility Testing Kits
    • 7.1.4 Cardiac Markers
    • 7.1.5 Infectious Diseases Testing Kits
    • 7.1.6 Drug-of-Abuse Testing Kits
    • 7.1.7 Others

8. Point-of-Care Testing Market, By Region

  • 8.1 Introduction
    • 8.1.1 North America
    • 8.1.2 Europe
    • 8.1.3 Asia Pacific
    • 8.1.4 Rest of the World

9. Industry Trends and Developments

  • 9.1 Portable Ultrasound Providing Care on Site
  • 9.2 Microfluidics Technology Crowding the POCT Industry

10. Company Profiles

  • 10.1 Becton, Dickinson and Company
  • 10.2 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
  • 10.3 Siemens Healthineers
  • 10.4 Danaher Corporation
  • 10.5 Abbott Laboratories
  • 10.6 Johnson & Johnson
  • 10.7 OraSure Technologies, Inc.
  • 10.8 Thermo Fisher Scientific Inc.
  • 10.9 Medtronic plc

List of Figures

  • Figure 3-1: Global - Diabetes Incidence (Million), 2015 & 2040
  • Figure 3-2: Global - In Vitro Diagnostic Market (Billion US$), 2017-2022
  • Figure 6-1: Global - Share of Point-of-Care Testing in the IVD Market (%), 2017
  • Figure 6-2: Global - Share of Point-of-Care Testing in the IVD Market (%), 2022
  • Figure 6-3: Global - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 7-1: Global - Point-of-Care Testing Market by Product (%), 2017
  • Figure 7-2: Global - Point-of-Care Testing Market by Product (%), 2022
  • Figure 7-3: Global - Glucose Monitoring Kits Market (Billion US$), 2017-2022
  • Figure 7-4: Global - Blood Gas and Electrolyte Analyzers Market (Billion US$), 2017-2022
  • Figure 7-5: Global - Pregnancy & Fertility Testing Kits Market (Billion US$), 2017-2022
  • Figure 7-6: Global - Cardiac Markers Market (Billion US$), 2017-2022
  • Figure 7-7: Global - Infectious Diseases Testing Kits Market (Billion US$), 2017-2022
  • Figure 7-8: Global - Drug-of-Abuse Testing Kits Market (Billion US$), 2017-2022
  • Figure 7-9: Global - Other POC Testing Kits Market (Billion US$), 2017-2022
  • Figure 8-1: Global - Point-of-Care Testing Market by Region (%), 2017
  • Figure 8-2: Global - Point-of-Care Testing Market by Region (%), 2022
  • Figure 8-3: North America - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 8-4: Europe - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 8-5: Asia Pacific - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 8-6: Rest of the World - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 10-1: Becton, Dickinson and Company - Revenue by Segment (%), 2017
  • Figure 10-2: Becton, Dickinson and Company - Revenue by Geography (%), 2017
  • Figure 10-3: Roche Diagnostics - Revenue by Segment (%), 2017
  • Figure 10-4: Danaher Corporation - Revenue by Segment (%), 2017
  • Figure 10-5: Danaher Corporation - Revenue by Geography (%), 2017
  • Figure 10-6: Abbott Laboratories - Revenue by Segment (%), 2017
  • Figure 10-7: Abbott Laboratories - Revenue by Geography (%), 2017
  • Figure 10-8: Johnson & Johnson - Revenue by Segment (%), 2017
  • Figure 10-9: Johnson & Johnson - Medical Devices Revenue by Segment (%), 2017
  • Figure 10-10: Johnson & Johnson - Revenue by Geography (%), 2017
  • Figure 10-11: Johnson & Johnson - Medical Devices Revenue by Geography (%), 2017
  • Figure 10-12: OraSure Technologies, Inc. - Revenue by Segment (%), 2017
  • Figure 10-13: OraSure Technologies, Inc. - OSUR Revenue by Segment (%), 2017
  • Figure 10-14: OraSure Technologies, Inc. - Revenue by Geography (%), 2017
  • Figure 10-15: Thermo Fisher Scientific Inc. - Revenue by Segment (%), 2017
  • Figure 10-16: Thermo Fisher Scientific Inc. - Revenue by Geography (%), 2017
  • Figure 10-17: Medtronic plc - Revenue by Segment (%), 2017
  • Figure 10-18: Medtronic plc - Revenue by Geography (%), 2017

List of Tables

  • Table 7-1: Frequently used Point-of-Care Glucose Monitoring Devices
  • Table 7-2: Differences between the Blood Gas Analyzer and Auto-Analyzer
  • Table 7-3: Home Pregnancy Test Kits
  • Table 10-1: Becton, Dickinson and Company - Net Sales (Million US$), 2015-2017
  • Table 10-2: Becton, Dickinson and Company - Product Portfolio for Point-of-Care Testing
  • Table 10-3: Roche Diagnostics - Net Sales (Million US$), 2015-2017
  • Table 10-4: Roche Diagnostics - Product Portfolio for Point-of-Care Testing
  • Table 10-5: Siemens Healthineers - Net Sales (Million US$), 2015-2017
  • Table 10-6: Siemens Healthineers - Product Portfolio for Point-of-Care Testing
  • Table 10-7: Danaher Corporation - Net Sales (Million US$), 2015-2017
  • Table 10-8: Danaher Corporation - Product Portfolio for Point-of-Care Testing
  • Table 10-9: Abbott Laboratories - Net Sales (Million US$), 2015-2017
  • Table 10-10: Abbott Laboratories - Product Portfolio for Point-of-Care Testing
  • Table 10-11: Johnson & Johnson - Net Sales (Million US$), 2015-2017
  • Table 10-12: Johnson & Johnson - Product Portfolio for Point-of-Care Testing
  • Table 10-13: OraSure Technologies, Inc. - Net Sales (Million US$), 2015-2017
  • Table 10-14: OraSure Technologies, Inc. - Product Portfolio for Point-of-Care Testing
  • Table 10-15: Thermo Fisher Scientific Inc. - Net Sales (Million US$), 2015-2017
  • Table 10-16: Thermo Fisher Scientific Inc. - Product Portfolio for Point-of-Care Testing
  • Table 10-17: Medtronic plc - Net Sales (Million US$), 2015-2017
  • Table 10-18: Medtronic plc - Product Portfolio for Point-of-Care Testing
Back to Top